Tirzepatide is a research-grade dual-acting glucagon-like peptide agonist designed for studies in metabolic regulation and body composition. This compound targets both GLP-1 and GIP receptor pathways, enabling investigations into dual incretin signaling and its downstream metabolic effects.
Research has examined how dual GLP-1/GIP receptor activation may produce complementary effects on glucose homeostasis, appetite regulation, and energy metabolism. Studies in preclinical models have explored the compound’s influence on pancreatic function, gastrointestinal motility, and central appetite centers. The dual-agonist design provides researchers with a tool to study receptor crosstalk and synergistic metabolic signaling.
Each vial contains 20mg of lyophilized GLP2-TZ, synthesized under GMP conditions with purity verified at greater than 98% by HPLC. Additional quality checks include mass spectrometry and endotoxin testing. Certificate of analysis available upon request.
Storage: Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 60 days.
For research and laboratory use only.
Reviews
There are no reviews yet.